These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9375888)

  • 1. Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group.
    van der Heijde D; Bellamy N; Calin A; Dougados M; Khan MA; van der Linden S
    J Rheumatol; 1997 Nov; 24(11):2225-9. PubMed ID: 9375888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis.
    van der Heijde D; Calin A; Dougados M; Khan MA; van der Linden S; Bellamy N
    J Rheumatol; 1999 Apr; 26(4):951-4. PubMed ID: 10229426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measures of outcome in ankylosing spondylitis and other spondyloarthritides.
    van der Heijde DM; van der Linden S
    Baillieres Clin Rheumatol; 1998 Nov; 12(4):683-93. PubMed ID: 9928502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the effect of interventions for axial spondyloarthritis according to the endorsed ASAS/OMERACT core outcome set: a meta-research study of trials included in Cochrane reviews.
    Andreasen RA; Kristensen LE; Baraliakos X; Strand V; Mease PJ; de Wit M; Ellingsen T; Hansen IMJ; Kirkham J; Wells GA; Tugwell P; Maxwell L; Boers M; Egstrup K; Christensen R
    Arthritis Res Ther; 2020 Jul; 22(1):177. PubMed ID: 32711571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How well are the ASAS/OMERACT Core Outcome Sets for Ankylosing Spondylitis implemented in randomized clinical trials? A systematic literature review.
    Bautista-Molano W; Navarro-Compán V; Landewé RB; Boers M; Kirkham JJ; van der Heijde D
    Clin Rheumatol; 2014 Sep; 33(9):1313-22. PubMed ID: 24970597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV.
    van der Heijde D; van der Linden S; Bellamy N; Calin A; Dougados M; Khan MA
    J Rheumatol; 1999 Apr; 26(4):945-7. PubMed ID: 10229424
    [No Abstract]   [Full Text] [Related]  

  • 7. Responsiveness and discriminative capacity of the assessments in ankylosing spondylitis disease-controlling antirheumatic therapy core set and other outcome measures in a trial of etanercept in ankylosing spondylitis.
    Wanders AJ; Gorman JD; Davis JC; Landewe RB; van der Heijde DM
    Arthritis Rheum; 2004 Feb; 51(1):1-8. PubMed ID: 14872448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment trials in ankylosing spondylitis: current and future considerations.
    van der Heijde D; Braun J; McGonagle D; Siegel J
    Ann Rheum Dis; 2002 Dec; 61 Suppl 3(Suppl 3):iii24-32. PubMed ID: 12381508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic comparison between rheumatoid arthritis and ankylosing spondylitis: an introduction.
    Braun J; Sieper J; Pincus T
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S1-2. PubMed ID: 19822037
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessments in ankylosing spondylitis.
    Zochling J; Braun J
    Best Pract Res Clin Rheumatol; 2007 Aug; 21(4):699-712. PubMed ID: 17678831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ankylosing spondylitis: plenary discussion and results of voting on selection of domains and some specific instruments.
    van der Heijde D; van der Linden S; Dougados M; Bellamy N; Russell AS; Edmonds J
    J Rheumatol; 1999 Apr; 26(4):1003-5. PubMed ID: 10229437
    [No Abstract]   [Full Text] [Related]  

  • 12. World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials.
    Boers M; Tugwell P; Felson DT; van Riel PL; Kirwan JR; Edmonds JP; Smolen JS; Khaltaev N; Muirden KD
    J Rheumatol Suppl; 1994 Sep; 41():86-9. PubMed ID: 7799394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of ankylosing spondylitis.
    Zochling J; Braun J
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S133-41. PubMed ID: 16273797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical management of ankylosing spondylitis.
    Khalessi AA; Oh BC; Wang MY
    Neurosurg Focus; 2008; 24(1):E4. PubMed ID: 18290742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The assessment of ankylosing spondylitis in clinical practice.
    Sengupta R; Stone MA
    Nat Clin Pract Rheumatol; 2007 Sep; 3(9):496-503. PubMed ID: 17762848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessments in ankylosing spondylitis.
    Zochling J; Braun J; van der Heijde D
    Best Pract Res Clin Rheumatol; 2006 Jun; 20(3):521-37. PubMed ID: 16777580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ankylosing spondylitis. Not just another pain in the back.
    Maksymowych WP
    Can Fam Physician; 2004 Feb; 50():257-62. PubMed ID: 15000337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis.
    Braun J; Davis J; Dougados M; Sieper J; van der Linden S; van der Heijde D;
    Ann Rheum Dis; 2006 Mar; 65(3):316-20. PubMed ID: 16096329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Objective evaluation of physical functioning after tumor necrosis factor inhibitory therapy in patients with ankylosing spondylitis: a selection of 3 feasible performance-based tests.
    van Weely SF; Dekker J; Steultjens MP; van Denderen JC; Nurmohamed MT; Dijkmans BA; van der Horst-Bruinsma IE
    J Rheumatol; 2015 Apr; 42(4):623-9. PubMed ID: 25593234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ankylosing spondylitis and symptom-modifying vs disease-modifying therapy.
    Akkoc N; van der Linden S; Khan MA
    Best Pract Res Clin Rheumatol; 2006 Jun; 20(3):539-57. PubMed ID: 16777581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.